Perioperative strategies for resectable EGFR-Mutant NSCLC: evidence hierarchy and clinical decision-making.

Tagrisso (osimertinib) - AstraZeneca

Semena (befotertinib) - InventisBio, Betta Pharma

Ameile (aumolertinib) - Jiangsu Hansoh Pharma

Ivesa (firmonertinib) - Allist, ArriVent

http://www.ncbi.nlm.nih.gov/pubmed/42033967

Bo Tang; Jigang Dai; Jingsi Wang; Qin Long; Quanxing Liu; Shengliang Zhao; Xiaoqing Liu; Xingwei Tang; Yingjiu Jiang

Apr 26, 2026